Bioliberty secures £1.5 million pre-Series A financing
Archangels, Eos Advisory, Old College Capital and Hanna Capital SEZC backed the rehabilitation technology company.
Bioliberty secured £1.5 million in pre-Series A financing from Archangels, Eos Advisory, Old College Capital and Hanna Capital SEZC. The financing was reported on June 21, 2025.
The company develops robotic rehabilitation technology for people recovering from stroke and other neurological conditions. Its systems combine assisted movement with interactive therapy and data that helps clinicians track recovery.